Itemoids

You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

Zepbound

since

auto-detected in 36 stories

4 days ago

Danish pharma company says Eli Lilly using outdated trial data to make its weight-loss drugs appear more effective

Ozempic maker Novo Nordisk said on Tuesday it is suing arch US rival Eli Lilly over “…

58 days ago

CVS will add Zepbound coverage on Oct. 1, and start covering Lilly's newly approved Foundayo pill on June 1.

86 days ago

First-quarter sales of medication Zepbound increased 80 per cent to $4.2bn
Lilly hiked its full-year sales outlook by $2 billion, and also raised its adjusted profit guidance.

4 months ago

Lilly is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound and its upcoming pill, orforglipron.
The maker of blockbuster weight-loss drugs Mounjaro and Zepbound has issued an urgent warning against knockoff versions of the medications over 'critical safety issues.'
Eli Lilly hopes the device can be more convenient for Zepbound users and lead to more people taking the drug.

5 months ago

Eli Lilly said on Wednesday the combined use of its weight-loss drug Zepbound with psoriasis treatment Taltz showed better results in a late-stage ​study.

Tablets could make treatment more mainstream, with sector predicted to be worth $200bn by end of the decade

“I just felt slow: I want to be able to do anything my kids want to do and not have weight b…

Combined sales for the company's blockbuster GLP-1 drugs Zepbound and Mounjaro exceeded $1 billion, with each showing triple-digit growth.

page 1 of 4 last →|